A Bioequivalence Study Comparing Cilnidipine/Valsartan Combination With Coadministration of Cilnidipine and Valsartan

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

A Randomized, Open-label, Single Dosing, Two-way Crossover Clinical Trial to Compare the Safety/Tolerability and Pharmacokinetics of the Combination of Cilnidipine 10mg and Valsartan 160mg in Comparison to Each Component Coadministered in Healthy Male Volunteers

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: IlDong Pharmaceutical Co Ltd
• Treatments: Cilnidipine; Valsartan

Criteria

Inclusion Criteria:

• Age between 20 and 40

• Signed informed consent

Exclusion Criteria:

• Has a history of hypersensitivity to IP ingredients

• Hypertension of hypotension